跳至主要内容
临床试验/NCT01493739
NCT01493739Unknown不适用

EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy

Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Diagnostic rate

研究概览

简要总结

This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.

详细描述

A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • mediastinal lymphadenopathy on Chest CT scan
  • with a short-axis > 10mm

排除标准

  • patients intolerant to bronchoscopy exam
  • unstable vital sign (Blood pressure, heart rate, breath rate)

结局指标

主要结局

Diagnostic rate

时间窗: Participant will be followed within an average of three months

次要结局

未报告次要终点

研究者

发起方
Chang Gung Memorial Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

CHIH-HSI KUO

Principle Investigator, Consultant Physician, Respiratory Medicine Department

Chang Gung Memorial Hospital

研究点 (1)

Loading locations...

相似试验

EBUS-TBNA for Diagnosis of Mediastinal... | 临床试验